Train2Target

  • Project
  • Network
    • Beneficiaries
    • Partner Organisations
    • Members Area
  • People
    • Supervisors
    • Early Stage Researchers (ESR) >
      • ESR 1: Carlos Gurnani
      • ESR 2: Tiago Baeta
      • ESR 3: Mitja Zdouc
      • ESR 4: Raquel Rodriguez
      • ESR 5: Jessica El-Rayes
      • ESR 6: Laureen Mertens
      • ESR 7: Elisa Consoli
      • ESR 8: Matthias Winkle
      • ESR 9: Kara Staunton
      • ESR 10: Pilar García del Vello
      • ESR 11: Elisabete Cardoso
      • ESR 12: Valentina Lucchini
      • ESR 13: Arancha Lopez
      • ESR 14: Federico Corona
      • ESR 15: Carina Matias
    • Scientific Advisory Board
  • Training
    • Training Plan
    • Annual Meeting 2019
    • Annual Meeting 2018
    • Annual Meeting 2017
  • Research
    • Workplan
    • Publications
  • Conferences
  • News
  • Project
  • Network
    • Beneficiaries
    • Partner Organisations
    • Members Area
  • People
    • Supervisors
    • Early Stage Researchers (ESR) >
      • ESR 1: Carlos Gurnani
      • ESR 2: Tiago Baeta
      • ESR 3: Mitja Zdouc
      • ESR 4: Raquel Rodriguez
      • ESR 5: Jessica El-Rayes
      • ESR 6: Laureen Mertens
      • ESR 7: Elisa Consoli
      • ESR 8: Matthias Winkle
      • ESR 9: Kara Staunton
      • ESR 10: Pilar García del Vello
      • ESR 11: Elisabete Cardoso
      • ESR 12: Valentina Lucchini
      • ESR 13: Arancha Lopez
      • ESR 14: Federico Corona
      • ESR 15: Carina Matias
    • Scientific Advisory Board
  • Training
    • Training Plan
    • Annual Meeting 2019
    • Annual Meeting 2018
    • Annual Meeting 2017
  • Research
    • Workplan
    • Publications
  • Conferences
  • News

News

Latest EU-wide data indicates that last-line antibiotics are failing

11/18/2016

1 Comment

 
A new report from the European Centre for Disease Prevention and Control (ECDC) reveals that resistance has continued to increase across Europe in spite of attempts to raise global awareness of the danger to the fundamentally important antibiotic class of drugs. Without them, some infectious diseases could become untreatable and some forms of major surgery would again become perilous.
The report, released on the occasion of the 9th European Antibiotic Awareness Day, is based on the latest EU-wide data on antibiotic resistance and antibiotic consumption. In 2015, antibiotic resistance continued to increase for most bacteria and antibiotics under surveillance. In particular, the EU average percentage of carbapenem resistance in Klebsiella pneumoniae increased from 6.2% in 2012 to 8.1% in 2015, and combined resistance to carbapenems and polymyxins (e.g. colistin) was sometimes reported. These two groups of antibiotics are considered last-line antibiotics as they usually are the last treatment options for patients infected with bacteria resistant to other available antibiotics. While antibiotic consumption in hospitals significantly increased in several EU Member States, antibiotic consumption in the community decreased in six EU Member States.
See more
1 Comment

The O'Neill Report: a review on antimicrobial resistance

11/14/2016

1 Comment

 
An influential report sponsored by the British Government and assembled by Lord Jim O’Neill suggests that the scourge of antimicrobial resistance can be effectively tackled. By launching targeted public awareness campaigns about the proper use of antibiotics, reducing the intake of antibiotics by livestock and humans, and simultaneously increasing the number of antibiotics available on the shelves, the O’Neill report concludes that combating antimicrobial resistance is not just possible, but also affordable. While the economic cost of antimicrobial resistance is predicted to be $100 trillion a year by 2050, the cost of action against rising resistance is estimated to be a much more modest $40 billion dollars a decade. Furthermore, the report provides accompanying recommendations to reduce resistance that include prohibiting the use of antibiotics that are vital to humans in livestock, carefully surveying the administration of drugs in developing countries, improving sanitation and hygiene to reduce risk of infection and disease, using rapid and specific diagnostic techniques to distinguish between bacterial infections and other infections, administrating vaccines and other alternatives to antibiotics, and forming an international coalition for action and a global innovation fund.
TACKLING DRUG-RESISTANT
INFECTIONS GLOBALLY:
FINAL REPORT AND RECOMMENDATIONS.
THE REVIEW ON ANTIMICROBIAL RESISTANCE
Read the full report
1 Comment

    Archives

    July 2020
    December 2019
    November 2019
    October 2019
    September 2019
    June 2019
    May 2019
    March 2019
    February 2019
    October 2018
    September 2018
    February 2018
    October 2017
    April 2017
    November 2016

    Categories

    All
    Antibiotics
    Report
    Resistance

    RSS Feed

Picture
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 721484.

© accelopment Schweiz AG 2019. ALL RIGHTS RESERVED.
Disclaimer | Members Area